Notice for atezolizumab (Roche Products Pty Limited)
Active ingredients
atezolizumab
Sponsor
Date of review outcome
Lapse date
Type
Orphan drug
Dosage form(s)
Concentrated injection
Indication
Treatment of hepatocellular carcinoma
Therapeutic area
Oncology